SCHEMBL29167130

SCHEMBL29167130

Nc1nc(N)nc(NCc2ccncc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.57
CA2 P00918 2/20 0.57
CA9 Q16790 2/20 0.57
KCNH3 Q9ULD8 2/20 0.54
NPSR1 Q6W5P4 1/20 0.53
GPR68 Q15743 5/20 0.49
ADRA2C P18825 1/20 0.44
ADORA2A P29274 2/20 0.44
HTR2B P41595 1/20 0.44
HTR1A P08908 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
APP P05067 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3301514 0.82 NPSR1 (0.74) CA1CA2CA9KCNH3NPSR1
Hydrochloric Acid SCHEMBL9247173 0.80 NPSR1 (0.72) CA1CA2CA9KCNH3NPSR1
SCHEMBL2456028 0.78 CA1 (0.60) CA1CA2CA9NPSR1GPR68
SCHEMBL14869710 0.78 CA1 (0.60) CA1CA2CA9NPSR1ADORA2A
SCHEMBL6838173 0.78 CA9 (0.60) CA1CA2CA9NPSR1GPR68
SCHEMBL29223873 0.78 CA1 (0.60) CA1CA2CA9KCNH3NPSR1
SCHEMBL11757124 0.78 MEN1 (0.62) NPSR1HDAC3HDAC1HDAC2HDAC6
SCHEMBL30784987 0.78 MEN1 (0.62) NPSR1HDAC3HDAC1HDAC2HDAC6
SCHEMBL30784980 0.78 MEN1 (0.62) NPSR1HDAC3HDAC1HDAC2HDAC6
SCHEMBL6727019 0.78 NPSR1 (0.74) CA1CA2CA9KCNH3NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117624137-A Triazine skeleton small molecule heparin reversal agent and preparation method and application thereof 中国药科大学 2024-03-01 CN disclosed